Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179166 · ClinicalTrials.gov registry record · Phase 2
Assessment of Metabolic Response in Critically Ill Patients With Acute Renal Failure
A Phase 2 study, sponsored by Vanderbilt University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT00179166: Clinical Trial Phase 2 study, sponsored by Vanderbilt University.
NCT00179166 is a Phase 2 study that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 3 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00179166, a Phase 2 study, was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
We hypothesize that a nutritional supplementation with higher than standard protein content (2.0 gm/Kg/day vs 1.4 gm/Kg/day) will result in improved whole-body net protein balance when administered to critically ill patients with acute renal failure (ARF).
Interventions
- DRUG TPN nutritional supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2004-06 |
| Est. Completion | 2005-07 |
| Phase | Phase 2 |
Why NCT00179166 stopped before completion
NCT00179166 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which TPN nutritional supplement is the first listed.
NCT00179166 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00179166 about?
NCT00179166 is a clinical study titled "Assessment of Metabolic Response in Critically Ill Patients With Acute Renal Failure". We hypothesize that a nutritional supplementation with higher than standard protein content (2.0 gm/Kg/day vs 1.4 gm/Kg/day) will result in improved whole-body net protein balance when administered to critically ill patients with acute renal failure (ARF).
What is the current status of trial NCT00179166?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2004-06. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00179166?
The interventions under investigation include: TPN nutritional supplement (DRUG).
Who is sponsoring clinical trial NCT00179166?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00179166's enrollment target sits among peer trials
3 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia